Page last updated: 2024-11-11

5,8-epidioxyergosta-6,9(11),22-trien-3-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

5,8-epidioxyergosta-6,9(11),22-trien-3-ol: from Ganoderma lucidum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11112737
CHEMBL ID449356
MeSH IDM0197692

Synonyms (8)

Synonym
CHEMBL449356
5,8-epidioxyergosta-6,9(11),22-trien-3-ol
86363-50-0
(1s,2r,5r,6r,10r,13s,15s)-5-[(e,2r,5r)-5,6-dimethylhept-3-en-2-yl]-6,10-dimethyl-16,17-dioxapentacyclo[13.2.2.01,9.02,6.010,15]nonadeca-8,18-dien-13-ol
5a,8a-epidioxyergosta-6,9(11),22-trien-3
HY-N7175
CS-0103795
FS-8080
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID309819Antibacterial activity against Pseudomonas aeruginosa ATCC 277532007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID744418Cytotoxicity against human A549 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID744420Cytotoxicity against human MCF7 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID1676606Cytotoxicity against human MCF7 cells assessed as reduction in cell viability <= 100 uM after 24 hrs by MTT assay
AID309816Antibacterial activity against Mycobacterium tuberculosis H37Rv by microdilution resazurin assay2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID309818Antibacterial activity against Escherichia coli ATCC 259232007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID744419Cytotoxicity against human MDA-MB-231 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID309820Antifungal activity against Candida sp.2007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID1676603Cytotoxicity against human MCF7 cells assessed as reduction in cell viability at 100 nM after 24 hrs in presence of ER antagonist ICI 182,780 by MTT assay
AID489306Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294 in stationary phase culture at pH 5.8 up to 200 ug/ml after 3 days followed by washout from day 4 to week 4 by microbroth dilution method2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum.
AID489305Antituberculosis activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 2 weeks by microbroth dilution method2010Bioorganic & medicinal chemistry letters, Jul-15, Volume: 20, Issue:14
In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum.
AID744421Cytotoxicity against human HepG2 cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
AID309817Antibacterial activity against staphylococcus aureus ATCC 259232007Bioorganic & medicinal chemistry letters, Nov-15, Volume: 17, Issue:22
New biologically active epidioxysterols from Stereum hirsutum.
AID744422Cytotoxicity against human Hep3B cells2013Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9
Spirostanoids with 1,4-dien-3-one or 3β,7α-diol-5,6-ene moieties from Solanum violaceum.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]